- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Camrelizumanb plus TPF
I alt 7726 resultater
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringParanasal bihulekræft | Induktionskemoterapi | Camrelizumab | Kræft i næsehulen | Intensitetsmoduleret strålebehandling | Samtidig kemoterapiKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityIkke rekrutterer endnu
-
Jiangxi Provincial Cancer HospitalRekruttering
-
The First Affiliated Hospital of Zhengzhou UniversityRekrutteringEsophageal Cancer af AJCC V8 StageKina
-
Juan A. ArnaizUkendt
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-operabelt hepatocellulært karcinomKina
-
Pakistan Institute of Living and LearningAfsluttet
-
Peking University Third HospitalIkke rekrutterer endnu
-
The First Affiliated Hospital of Zhengzhou UniversityIkke rekrutterer endnuEsophageal pladecellekarcinom
-
Peking University People's HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Tilmelding efter invitationGermline BRCA-muteret HER2-negativ brystkræftKina
-
wang shusenRekrutteringAvanceret HER2 negativ brystcarcinom HRD+brystkræftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Nanfang Hospital of Southern Medical UniversityJiangsu HengRui Medicine Co., Ltd.RekrutteringHepatocellulært karcinomKina
-
Peking University First HospitalIkke rekrutterer endnuImmunterapi | SBRT | Stor tumor
-
Gilead SciencesAfsluttetHIV-infektioner | HIVForenede Stater, Det Forenede Kongerige, Sverige, Frankrig, Puerto Rico, Holland, Italien, Portugal, Canada, Mexico, Dominikanske republik
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
Guangdong Association of Clinical TrialsIkke rekrutterer endnuIkke-småcellet lungekræft
-
Beijing Sanbo Brain HospitalRekrutteringPrimært centralnervesystem lymfomKina
-
Guangdong Association of Clinical TrialsUkendt
-
Guiyang Medical UniversityRekrutteringLokalt avanceret nasopharyngealt karcinomKina
-
The First Affiliated Hospital with Nanjing Medical...RekrutteringKolorektal neoplasmaKina
-
Abbott Rapid DxBill and Melinda Gates FoundationAfsluttet
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Peking Union Medical College HospitalRekrutteringEffekt og sikkerhed af Camrelizumab Plus S-1 vedligeholdelse efter førstelinjeinduktionskemoterapi til GCKina
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Provincial HospitalUkendt
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringAvanceret HER2 negativ brystkarcinom | HRD+brystkræftKina
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuEsophageal pladecellekarcinom | Progression til PD-1 antistofKina
-
Shanghai YingLi Pharmaceutical Co. Ltd.Ikke rekrutterer endnu
-
Zhejiang Cancer HospitalRekrutteringHjernemetastaser | NSCLC trin IV | ImmunterapiKina
-
Sun Yat-sen UniversityRekrutteringNasopharyngealt karcinomKina
-
Huazhong University of Science and TechnologyThe First Affiliated Hospital of Nanchang UniversityRekrutteringLymfom | Tilbagefald/GentagelseKina
-
Beijing 302 HospitalRekrutteringKronisk hepatitis BKina
-
Shanghai Ninth People's Hospital Affiliated to...RekrutteringOralt planocellulært karcinomKina
-
Sun Yat-sen UniversityGuangdong Provincial People's Hospital; Affiliated Cancer Hospital & Institute... og andre samarbejdspartnereRekrutteringNasopharyngealt karcinomKina
-
Wan-Guang ZhangRekrutteringMakrotrabekulært massivt hepatocellulært karcinomKina
-
PfizerAfsluttetFedme | OvervægtigForenede Stater
-
Jiangsu HengRui Medicine Co., Ltd.Tilmelding efter invitation
-
First Affiliated Hospital Xi'an Jiaotong UniversityIkke rekrutterer endnu
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekrutteringAvanceret hepatocellulært karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... og andre samarbejdspartnereRekrutteringEsophageale neoplasmerKina
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterendeAdjuverende terapi hos patienter med hepatocellulært karcinom (HCC) med høj risiko for tilbagefald efter kurativ resektion eller ablationKina
-
Hebei Medical University Fourth HospitalRekruttering
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRekrutteringLevertransplantation | Hepatocellulært karcinomKina
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetNasopharyngealt karcinomKina
-
Qian ChuJiangsu HengRui Medicine Co., Ltd.Rekruttering